Catalent Appoints Nakaya Matsumaru as General Manager of its N... - 11 December 2020 13:30

SOMERSET, N.J., Dec. 11, 2020 /PRNewswire-AsiaNet/ -- Catalent, the leading global provider of advanced delivery technologies, development, manufacturing and clinical supply solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced the appointment of Nakay...

  DETECT program studies validate clinical relevance of CTC HER2... - 11 December 2020 01:12

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Dec. 10, 2020 /PRNewswire-AsiaNet/ -- - Results presented at the 2020 San Antonio Breast Cancer Symposium confirm the relevance of screening for HER2+ CTCs from blood samples in patients with a HER2 negative primary tumor biopsy to optimize treatment strategy and patient outcome Me...

  INOVIO and Advaccine Announce First Dosing of Subject in Phase... - 11 December 2020 00:00

PLYMOUTH MEETING, Pa. and SUZHOU, China, Dec. 10, 2020 /PRNewswire-AsiaNet/ -- -- Dosing marks a key milestone for INO-4800 in China and its second Phase 2 clinical trial globally INOVIO (NASDAQ: INO), a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...

  Kazia to Collaborate with Pacific Pediatric Neuro-Oncology Con... - 10 December 2020 16:22

SYDNEY, Dec. 10, 2020 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it has executed a Letter of Intent with the Pacific Pediatric Neuro-Oncology Consortium (PNOC) to launch a clini...

  iHerb Announces Exciting New Ways to Earn with iHerb's Rewards... - 10 December 2020 06:33

PASADENA, Calif., Dec. 10, 2020 /PRNewswire-AsiaNet/ -- iHerb, a global leader in health and beauty e-commerce, announces ground-breaking new updates to their Rewards program with even more exciting ways to earn Rewards. Logo - https://mma.prnewswire.com/media/1361351/UGCI_Review_Rewards_Talking_Po...

  New Global Pooled Analysis Supports Clinical Utility of Circul... - 10 December 2020 02:04

BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., December 9, 2020, /PRNewswire-AsiaNet/-- Menarini Silicon Biosystems [http://www.siliconbiosystems.com/ ], a pioneer of liquid biopsy technology, today announced the results of a pooled analysis of 14 clinical trials on the relevance of circulating tumor cell (CTC) count to predict both ...

  INOVIO's VGX-3100 Demonstrates Positive Phase 2 Efficacy In Tr... - 10 December 2020 00:00

PLYMOUTH MEETING, Pa., Dec. 9, 2020 /PRNewswire/ -- -- DNA immunotherapy candidate VGX-3100 demonstrated resolution of HPV-16/18-associated precancerous anal lesions in 50% of treated patients six months after treatment -- Current standard of care for anal dysplasia typically requires surgical ...

  Top-line Final Data from Cantrixil Phase I Study Confirms Prio... - 09 December 2020 11:38

SYDNEY, Dec. 9, 2020 /PRNewswire-AsiaNet/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share top-line final data from its phase I study of Cantrixil (TRX-E-002-1) in patients with persistent or recurrent ovarian c...

  Latest Global Survey from ISAPS Reports Continuing Rise in Aes... - 09 December 2020 04:00

HANOVER, N.H., Dec. 9, 2020 /PRNewswire-AsiaNet/ -- -- Total surgical and nonsurgical procedures increased by 7.4% in 2019 The International Society of Aesthetic Plastic Surgery (ISAPS) released the results of its annual Global Survey on Aesthetic/Cosmetic Procedures today, showing a 7.4% increa...

  TCAI at St. David's Medical Center hosts virtual international... - 09 December 2020 02:08

AUSTIN, Texas, Dec. 9, 2020 /PRNewswire-AsiaNet/ -- On December 3 and 4, 2020, the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center ( https://c212.net/c/link/?t=0&l=en&o=3005359-1&h=2863479803&u=https%3A%2F%2Ftcainstitute.com%2F&a=Texas+Cardiac+Arrhythmia+Institute+(TCAI)+at+...